ArticleChemSusChem2025
Tuning Crystal Growth of Colloidal Cs
Article in ChemSusChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tuning Crystal Growth of Colloidal CsChemSusChem · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Lead-free bismuth-based perovskite-like materials have emerged as promising alternatives to lead halide perovskites due to their enhanced stability and lower toxicity. Colloidal approaches for the synthesis of such materials offer the advantage of morphology engineering and precise control over size and shape. However, conventional approaches require long-chain organic ligands, which hinder charge transport and limit their applicability in optoelectronic devices. Herein, a ligand-free Solvent-Assisted Reprecipitation (SARP) approach is introduced, exploiting solvent-mediated synthesis to control the nucleation and growth of Cs
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.